HealthQuill Structure Reorganization
Emergent BioSolutions, will sack 400 employees across its various facilities to focus on core business products meant to treat opioid overuse, anthrax, Ebola and smallpox.
Drugs Health Pharma

Emergent BioSolutions to cut 400 jobs to focus on core products

HQ Team August 9, 2023: Emergent BioSolutions, will sack 400 employees across its various facilities to focus on core business products meant to.

Read More